Lakefront Biotherapeutics NV (GLPG) Form 6-K — Jul 28, 2026
Lakefront Biotherapeutics NV has repurchased 95,670 of its own ordinary shares between July 20 and July 24, 2026, as part of its ongoing share repurchase program. The total cost of the repurchased shares amounted to approximately €2.43 million, with an average purchase price of €25.41 per share. This activity falls under the share buyback program initially announced on June 9, 2026. Following these transactions, the company holds 606,719 of its own shares as of the market close on July 24, 2026.
Key figures
- Average Price Eur
- 25.41
- Repurchase Cost Eur
- €2,431,442.30
- Shares Repurchased
- 95670
- Treasury Shares Held
- 606719
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.